Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001762893-25-000005
Filing Date
2025-01-10
Accepted
2025-01-10 16:55:57
Documents
4
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1736546150.html 3  
1 FORM 3 wk-form3_1736546150.xml 3 1706
2 EX-24 crbu-xsection16poa_ryali.htm EX-24 4244
3 crbu-xsection16poa_ryali001.jpg GRAPHIC 204322
4 crbu-xsection16poa_ryali002.jpg GRAPHIC 33754
  Complete submission text file 0001762893-25-000005.txt   335458
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306
Business Address
Ryali Sriram (Reporting) CIK: 0001762893 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40631 | Film No.: 25523704